BCBS Arkansas Medical Policy Updates – August 2022

Click here to view the Blue Cross Blue Shield BCBS Arkansas Medical Policy Updates »

August 2022 BCBS Arkansas Medical Policy Updates:

• Ablation Therapy for Atrial Fibrillation (Pulmonary Venous Isolation, Radiofrequency, Cryoablation, AV Node Ablation)
• Adoptive Immunotherapy
• Aducanumab (e.g., Aduhelm)
• Air Ambulance
• Amivantamab-vmjw (e.g., Rybrevant™)
• Annuloplasty, Percutaneous Intradiscal: Electrothermal (IDET), Radiofrequency (PIRFT) or Biacuplasty
• Anti-PD-1 (programmed death receptor-1)Therapy (Pembrolizumab)(Nivolumab)
• Antithrombin III Replacement
• Biofeedback as a Treatment of Urinary Incontinence in Adults
• Biofeedback for Miscellaneous Indications
• Brachytherapy, Prostate, Low-dose Rate
• Canakinumab (e.g., Ilaris™)
• Cardiac Event Recorder, External Loop or Continuous Recorder
• Cardiac Event Recorder, Mobile Telemetry
• Carotid Intima -Media Thickness, Ultrasound Measurement to Assess Subclinical Atherosclerosis
• Chemical Peels
• Chronic Intermittent Intravenous Insulin Therapy (CIIIT)
• Computer-Assisted Musculoskeletal Surgical Navigational Orthopedic Procedure
• Corneal Collagen Cross-linking
• Coverage Policy Manual – Arkansas Blue Cross and Blue Shield
• Coverage Policy Manual – Arkansas Blue Cross and Blue Shield
• Covid-19 Monoclonal Antibody Therapy
• Cryosurgical Ablation of Breast Tumors, Benign and Malignant
• Cryosurgical Ablation of Pancreatic Cancer
• Cryosurgical Ablation of Renal Tumors
• Digital Breast Tomosynthesis
• Digital Health Therapies for Attention Deficit/Hyperactivity Disorder
• Digital Health Therapies for Substance Abuse
• Droxidopa (Northera™)
• Edaravone
• Electrical Stimulation, Transcutaneous Electrical Nerve Stimulator
• Electrical Stimulation, Vagus Nerve Stimulation for the Treatment of Obesity
• Food and Chemical Sensitivity Testing
• Genetic Test: Colon Cancer, Gene Expression Profiling (Oncotype DX, Colon PRS, Onco Defender-CRC, ColoPrint)
• Genetic Test: Facioscapulohumeral Muscular Dystrophy
• Genetic Test: Factor V Leid
• Genetic Test: Fecal DNA to Detect Colorectal Cancer, Screening
• Genetic Test: Germline Mutations of the RET Protooncogene in Medullary Carcinoma of the Thyroid
• Genetic Test: Inherited Thrombophilia, Prothrombin Gene Mutations (G20210A) and MTHFR Mutations
• Genetic Test: Mitochondrial Disorders
• Genetic Test: Mutation Testing for Limb-Girdle Muscular Dystrophies
• Genetic Test: Testing for the Diagnosis and Management of Mental Health Conditions
• Genetic Test: Universal Gene Test (Counsyl)
• Ground Ambulance
• Handheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins during Breast-Conserving Surgery
• Hysteroscopic Placement of Micro-Inserts in the Fallopian Tubes as a Form of Permanent Sterilization
• Immune Cell Function Assay
• Immune Globulin, Intravenous and Subcutaneous
• Intensity Modulated Radiation Therapy (IMRT), Anus, Anal Canal
• Interventions for Progressive Scoliosis
• Iobenguane I 131 (e.g., Azedra®)
• Ipilimumab (Yervoy™)
• Lutetium Lu 177 vipivotide tetraxetan (e.g., Pluvicto)
• Lymphedema Pumps (Pneumatic Compression Devices) for the Treatment of Lymphedema and Venous Ulcers
• Mastectomy, Prophylactic
• Measurement of Serum Intermediate Density Lipoproteins (Remnant-like Particles)
• Medical Technology Assessment, Non-Covered Services
• MR Guided Ultrasound Ablation – Uterine Fibroids and Other Tumors
• Multiple Sleep Latency/Maintenance of Wakefulness Test
• Nutritional Panel Testing (NutrEval®, ONE FMV™)
• Olaratumab (LARTRUVO™)
• Orthopedic Applications of Stem Cell Therapy
• Osteochondral Autograft Transfer (OATS) and/or Mosaicplasty For Osteochondral Defects of the Knee
• Paliperidone Palmitate (Long-acting Injectables Invega Sustenna ® & Invega Trinza)
• Pertuzumab, trastuzumab and hyaluronidase-zzxf (e.g., PHESGO™)
• PET Scans (Positron Emission Tomography)
• Posturography, Dynamic/Static
• Preventive Services for Non-Gradfathered (PPACA) Plans: Lung Cancer Screening
• Preventive Services for Non-Grandfathered (PPACA) Plans: Colorectal Cancer Screening
• Preventive Services for Non-Grandfathered (PPACA) Plans: Dental Caries Prevention in Preschool Children
• Preventive Services for Non-Grandfathered (PPACA) Plans: Hearing Loss Screening in Newborns UP to Age 21
• Preventive Services for Non-Grandfathered (PPACA) Plans: Hepatitis C Virus Screening
• Preventive Services for Non-Grandfathered (PPACA) Plans: Lead Screening in Infants and Children Through Age Six
• Preventive Services for Non-Grandfathered (PPACA) Plans: Overview
• Preventive Services for Non-Grandfathered (PPACA) Plans: Sickle Cell Disease, Newborn Screening
• Preventive Services for Non-Grandfathered (PPACA) Plans: Tobacco use, Screening, Counseling and Interventions
• Prolotherapy (Sclerotherapy)
• Prostatic Urethral Lift (UroLift System)
• Radiofrequency Ablation of Primary or Metastatic Liver Tumors
• Radiofrequency Treatment, Chronic Back Pain (Nucleoplasty)
• Repair of Durable Medical Equipment (DME) and External Prosthetic Devices
• Repository Corticotropin Injection
• Risankizumab (e.g., Skyrizi)
• Rituximab (e.g., Rituxan) and Biosimilars – Non-Oncologic Indications
• Samarium SM 153 lexidronam (Quadramet®)
• Self-Administered Medication
• Short Tandem Repeat Analysis for Specimen Provenance Testing (know error® system)
• Sphenopalatine Ganglion Block for Headache
• Surgical Deactivation of Headache Trigger Sites
• Telemedicine
• Total Facet Arthroplasty
• Transplant, Liver
• Treatment of Varicose Veins/Venous Insufficiency
• Tumor-Treating Fields Therapy for Glioblastoma (NovoTTF)
• Ultrasound Accelerated Fracture Healing Device
• Ultrasound in Maternity Care
• Vedolizumab (Entyvio) for Inflammatory Bowel Disease
• Ventricular Assist Devices

Click here to view the Blue Cross Blue Shield BCBS Arkansas Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.